Caption Management »

Kymera Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $8.5M 288k 29.63
2022-12-31 $17M 664k 24.96
2022-03-31 $2.6M 62k 42.35

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
Atlas Venture Life Science Advisors
T. Rowe Price Associates
BVF
Wellington Management Company
Vanguard Group
venBio Select Advisor
Artal Group
Redmile Group
Aquilo Capital Management
Goldman Sachs Group
Deer Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Norges Bank Investment Management

View all funds holding Kymera Therapeutics